This page contains details of ongoing consultations where the opinion and input of BIA members is sought.
If you are commenting on any consultation as an individual or on behalf of another organisation such as RCPath and you belong to the BIA please do copy your form to BIA@Hartleytaylor.co.uk. Responders will receive a BIA Guideline Review Support Certificate which can be used to self-credit up to 10 CPD points for commenting on a consultation and we will incorporate your individual/other organisation response into the response of the BIA.
The following consultations are currently open:
- Infectious Disease Undergraduate Curriculum - Survey. This survey is currently open
- PHE UK Guidelines for the Management of Contacts of Invasive Group A Streptococcus Infection in Community Settings. Please respond by 29th September 2017
- UK NSC consultation: guidance on the development, production and review of information to support screening. Please respond by 16th November 2017
- UK NSC consultation: antenatal screening for syphilis, HIV and hepatitis B. Please respond by 30th November 2017
- UK NSC consultation: antenatal screening for human t-cell lymphotrophic virus (HTLV). Please respond by 28th September 2017
The BIA and Imperial College London are developing an Infectious disease (ID) medical undergraduate curriculum using a Delphi model. The aim of the project is to set out the minimum ID knowledge, skills and attitudes all medical students should have by the time they qualify.
ROUNDS 1 and 2 of the BIA and Imperial College London's development of an Infection (Infectious disease, Microbiology) medical undergraduate curriculum using a Delphi model are complete! We appreciate the time taken to fill out these surveys.
We would be grateful if you could complete the FINAL ROUND 3 which should take 5 minutes
PHE UK Guidelines for the Management of Contacts of Invasive Group A Streptococcus Infection in Community Settings
Please send comments to Anna.Goodman@gstt.nhs.uk by 5pm, 29th September
UK NSC consultation: guidance on the development, production and review of information to support screening
The UK National Screening Committee (UK NSC) is consulting on its guidance covering the development, production and review of information to support all UK population screening programmes, and would welcome your comments on the draft guidance document.
The guidance document has been produced by a four-country task and finish group to fulfil a recommendation made by a 2014 Parliamentary Science and Technology Committee Report on national health screening.
For further information about the consultation, the draft guidance document and supporting appendices, please visit: https://legacyscreening.phe.org.uk/informed-choice-consultation. A blog about the consultation is available here.
The consultation closes on Thursday 16 November 2017. Please send your comments directly to us at this email address (UKNSCConsultation@phe.gov.uk).
The UK National Screening Committee has opened a consultation on the antenatal screening for syphilis, HIV and hepatitis B. The aim is to identify and evaluate any literature which could suggest that there is reason to remove any of these conditions from the NHS Infectious Diseases in Pregnancy Screening (IDPS) programme. Screening for these three conditions is currently offered to all pregnant women as part of their antenatal care.
Please click on the below hyperlinks to be taken to the respective consultation page:
A triage review has been produced for each condition which scanned the literature field for any red flags that suggest further exploration of the removal of the condition may be necessary.
It is important to note that these reviews have a surveillance function and are therefore not intended as a comprehensive review of the programme.
Please send comments to Anna.Goodman@gstt.nhs.uk by 30th November 2017.
The UK National Screening Committee (UK NSC) has started a national consultation on antenatal screening for human t-cell lymphotrophic virus (HTLV). More details of the consultation can be found on our website at https://legacyscreening.phe.org.uk/htlv.
We would welcome comments from you on the draft review which can be downloaded from the link below. The response form is also available here; please send any responses direct to the UK NSC by Thursday 28th September 2017. Please be aware that all responses will be published on the website after the UK NSC makes its final recommendation.
NICE: Implementation of changes to the arrangements for evaluating and funding drugs and other health technologies appraised through our technology appraisal (TA) and highly specialised technologies (HST) programmes
I am writing to you to make you aware of the implementation of changes to the arrangements for evaluating and funding drugs and other health technologies appraised through our technology appraisal (TA) and highly specialised technologies (HST) programmes effective from 01 April 2017.
In October 2016, we (NICE) launched a joint consultation with NHS England. In the consultation we proposed to:
- Operate a ‘budget impact threshold’ of £20 million, set by NHS England, to signal the need for a dialogue with companies to agree arrangements to better manage the introduction of new technologies recommended by NICE. This would apply to a small number of technologies that, once determined as cost effective by NICE, would have a significant impact on the NHS budget.
- Introduce a ‘fast track’ technology appraisal process for the most promising new technologies. These would fall below an incremental cost-effectiveness ratio of £10,000 per QALY (quality adjusted life year), to get these treatments to patients more quickly.
- Vary the timescale for the funding requirement when the budget impact threshold is reached or exceeded, and there is therefore a compelling case that the introduction of the new technology would risk disruption to the funding of other services.
Proposed changes to our drug evaluation process were put forward to the NICE Board for approval at their meeting on 15 March 2017.
If you responded to the consultation, we would like to take the opportunity to thank you for your valued contribution.
We’ve listened carefully to what stakeholders have been told us within the consultation and made some important changes, as well as adding detail to our proposals. Significantly, we will look at the feasibility of extending the fast-track appraisal process to a wider group of treatments – not just those with a likely cost per QALY of £10,000 or less.
What was previously known as the Abbreviated Technology Appraisal (ATA) process has also been absorbed into the Fast Track Appraisal (FTA) process, with the addition of ‘cost comparison’ methodology.
The NICE board also agreed proposals to introduce a £20 million budget impact test. The test will be used to trigger discussions about potential ‘commercial agreements’ between NHS England and companies in order to manage the budget impact of introducing high cost treatments. This will apply to both the technology appraisal (TA) and highly specialised technologies (HST) programmes
The following documentation is now available on the NICE website:
· October 2016; Joint consultation document
· March 2017; NICE Board paper
· March 2017; Consultation analysis
· April 2017; Procedure for varying the funding requirement to take account of net budget impact
· April 2017; Assessing resource impact process manual: technology appraisals and highly specialised technologies
· April 2017; Fast track appraisal - Addendum to the Guide to the Processes of Technology Appraisal
· April 2017; Cost comparison - Addendum to the Guide to the methods of Technology Appraisal
Existing submission templates have been updated to address the implementation of the changes, and new templates for the application of the cost comparison methodology are also available on the NICE website.
If you have any questions about these changes, please contact Jenniffer Prescott, Associate Director (Planning, Operations and Topic Selection) by email at email@example.com.
British Society for Rheumatology draft guidelines: Biological DMARD safety guidelines in inflammatory arthritis. Consultation closed 04/09/17.
NICE guidance on emergency and acute medical care in over 16s: service delivery and organisation. Consultation closed 14/08/17. Expected publication date: 20/12/17. Click for BIA comments submitted
NICE guideline on sore throat (acute): antimicrobial prescribing. Consultation closed 14/08/17. Expected publication date: 08/11/17. Click for BIA comments submitted
Stakeholder consultation: High Consequence Infectious Diseases Interim Paediatric. Consultation closed 19/07/17.
NICE draft guideline: Flu vaccination - increasing uptake. Expected publication date: 10/01/2018.
Click for BIA comments on this consultation
NICE Surveillance Reports - Healthcare associated infections: prevention and control in primary and community care. Survey closed 27/06/17.
UK SMI V 04 - Investigation of hepatitis B infection. Consultation closed 26/06/17.
NICE draft guideline on sinusitis (acute): antimicrobial prescribing. Consultation closed 23/06/17. Expected publication date: 25 August 2017.
NICE draft guideline on cystic fibrosis: diagnosis and management. Consultation closed 18/06/17. Expected publication date: October 2017. Click for BIA comments.
UK National Screening Committee consultation: screening for Group B Streptococcus in pregnancy. Consultation closed 25/01/17. Expected review completion date: March 2017.
Bezlotoxumab for preventing recurrent Clostridium difficile infection ID1068. Consultation closed 19/12/16
NICE Quality Standard Topic Engagement Exercise: HIV testing: encouraging uptake. Consultation closed 5/12/16.
NICE QS topic engagement exercise: Sepsis. Consultation closed 16/11/16.
NICE guideline on Managing Common Infections. Consultation closed 28/11/16. Expected publication date tbc.
NICE Quality Standard Consultation: Vaccine uptake in under 19's. Consultation closed 29/09/16. Expected publication date: January 2017.
NICE Diagnostics Consultation Document: Integrated multiplex PCR tests for identifying gastrointestinal pathogens in people with suspected gastroenteritis (xTAG Gastrointestinal Pathogen Panel, FilmArray GI Panel and Faecal Pathogens B assay). Consultation closed 09/09/16. Expected publication date: January 2017.
NICE guideline CG139 Healthcare-associated infections: prevention and control in primary and community care. Consultation on the decision NOT to update this guideline closed 02/09/16.
NICE Consultation on Abbreviated Technology Appraisal (ATA) Process. Consultation closed 24/08/16. Comments are currently being reviewed and an updated version is due to be presented to the NICE board in November 2016.
RCPath guidance on the communication of critical results. This document was produced by Dr Bernie Croal. This document was online for consultation from 20 July to 17 August 2016 and the author is now considering the feedback. Click for consultation document.
Report from the EUCAST Subcommittee on the role of whole genome sequencing (WGS) in antimicrobial susceptibility testing. Consultation closed 24/06/16.
NICE Guideline: Sickle cell disease: managing acute painful episodes in hospital - Surveillance consultation. Consultation closed 02/06/16. Anticipated review decision publication: August 2016
UK SMI V 37: Chlamydia trachomatis infection - testing by Nucleic Acid Amplification Tests (NAAT). Consultation closed 31/05/16. Feedback currently being analysed.
NICE draft guideline consultation: Multimorbidity: clinical assessment and management. Guideline published September 2016.
NICE Quality Standard consultation: Hip fracture (update). Consultation closed 5/5/16. Anticipated publication: November 2016.
NICE Quality Standards (update): Diabetes in adults. Update published August 2016. Click for BIA response.
NICE draft guideline consultation: Non-Hodgkin's lymphoma. Guideline published July 2016.
Nice quality standard topic engagement exercise: blood transfusion. Consultation closed 01/03/16. Anticipated publication: Dec 2016
NICE draft guideline consultation: Sepsis. Guideline published July 2016.
NICE quality standard consultation: Bronchiolitis in children. Quality standard published June 2016
NICE guidelines - Cirrhosis in over 16s: assessment and management. Guidelines published July 2016
Survey on UK-wide provision of travel medicine training. Survey closed 6 January 2016.
NICE draft guideline consultation: Improving supportive and palliative care in adults (update). Consultation closed 28 January 2016.
NICE survey on diagnostic services: current practice. Consultation closed 29 January 2016.